Updated Date:
10 Oct 2025
Product Detail:
KANJINTI trastuzumab 150 mg powder for injection vial
Shortage Status:
Discontinued
AUST R:
296881
Availability:
Reduction in supply until supply is exhausted
Active Ingredient:
Trastuzumab
Reason:
Commercial Changes / Commercial viability
Dosage Form:
Injection,powderfor
Supply Impact Dates
Management Action:
Alternative brands are available.
